Cargando…
Neuroprotective Agents with Therapeutic Potential for COVID-19
COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID. Moderate symptoms include ageusia, anosmia, altered m...
Autores principales: | Zaa, César A., Espitia, Clara, Reyes-Barrera, Karen L., An, Zhiqiang, Velasco-Velázquez, Marco A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669388/ https://www.ncbi.nlm.nih.gov/pubmed/38002267 http://dx.doi.org/10.3390/biom13111585 |
Ejemplares similares
-
Anthocyanins: Molecular Aspects on Their Neuroprotective Activity
por: Zaa, César A., et al.
Publicado: (2023) -
Wine Polyphenols: Potential Agents in Neuroprotection
por: Basli, Abdelkader, et al.
Publicado: (2012) -
Ginsenosides: A Potential Neuroprotective Agent
por: Zheng, Mengmeng, et al.
Publicado: (2018) -
Fiscalin Derivatives as Potential Neuroprotective Agents
por: Barreiro, Sandra, et al.
Publicado: (2022) -
Fetal Neuroprotective Strategies: Therapeutic Agents and Their Underlying Synaptic Pathways
por: Elsayed, Nada A., et al.
Publicado: (2021)